SINGULAIR PAED GRANULES 4 MG 28 S

Singulair is indicated in the treatment of asthma as add-on therapy in those 6 months to 5 year old patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “ as-needed” short acting β -agonists provide inadequate clinical control of asthma.

Directions to use :

as directed by the physician

Side effects :

upper respiratory infection, fever, and headache